基于SEER数据库的非早期透管道癌的动态条件生存名录
Erqing Tan1, Tingting Chen2, He Hao3
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Scientific reports
|November 21, 2025
概括
一个新的有条件生存名图为透管道癌 (IDC) 患者提供了更准确的长期生存预测. 这种动态模型改进了传统方法,有助于针对乳腺癌进行个性化治疗规划.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 癌症预后 癌症预后
背景情况:
- 透管道癌 (IDC) 是最常见的乳腺癌亚型,但长期存活率仍然不确定.
- 现有的生存预测方法,如Kaplan-Meier和TNM名谱,对非早期的IDC有局限性.
- 动态生存概率提供了更精确的预期寿命估计.
研究的目的:
- 为非早期透管道癌 (IDC) 患者开发条件生存 (CS) 预测模型.
- 加强在IIB期及以后的女性IDC患者的长期生存评估.
- 通过改善生存预测来支持个性化治疗规划.
主要方法:
- 利用了女性IDC患者的SEER数据库 (2000-2022) 的数据.
- 采用卡普兰-梅尔分析计算整体生存概率.
- 应用了拉索,子集回归和考克斯比例危险分析来构建CS名图.
主要成果:
- 开发的CS nomogram包含12个变量,并预测3年,5年和10年的生存期.
- 通过更高的一致性指数和改进的ROC曲线,CS nomogram表现出比TNM nomogram更高的预测准确性.
- 校准图和决策曲线分析 (DCA) 证实了CS名图的提高精度和临床实用性.
结论:
- 与传统的诺姆图相比,CS诺姆图为非早期IDC患者提供了更准确和个性化的生存预测.
- 这个动态工具根据已经生存的时间更新了生存估计 (CS(yidiyex)).
- 该CS nomogram为临床决策提供了宝贵的指导,并完善了生存率估计的准确性.
更多相关视频
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Dosage Regimen Designs: Nomograms and Tabulations
163
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
163


